Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
For the first time, researchers found that empagliflozin, an established diabetes and heart medication, reduced markers of brain injury while restoring blood flow in critical brain regions.
Endocrinology, Diabetes, Metabolism November 3rd 2025
Medical Xpress
As cannabis becomes more widely available and socially accepted and legalized in various jurisdictions, it is essential to understand its potential health risks and the need for health care professionals to routinely talk to patients about cannabis use.
Endocrinology, Diabetes, Metabolism September 15th 2025
GoodRx for Healthcare Professionals
Multiple medication classes cause weight gain through distinct mechanisms including enhanced glucose uptake, metabolic slowing, increased appetite, and fluid retention, requiring tailored management approaches.
Cardiology May 28th 2025
Epoch Health
Brain aging follows distinct stages with metabolic dysregulation beginning decades before symptoms appear, creating an opportunity for preventive intervention rather than reactive treatment.
Endocrinology, Diabetes, Metabolism April 30th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS